University of California-Los Angeles Medical Center / Urology Northwestern University / / /
IndustryTerm
benign prostatic hyperplasia treatment / treatment for benign prostatic hyperplasia / therapy for BPH / treatment for BPH / benign prostatic hyperplasia related services / Therapy of Prostatic Symptoms / BPH treatment / insurance health care claims database / spending on benign prostatic hyperplasia related services / calculated using a private insurance health care claims database / /
surgery Surgery / incision / herbal medicines / prostatectomy / laser coagulation / prostatectomies / surgery / surgical treatment / laser vaporization / Balloon dilation / thermotherapy / /
Organization
Department of Urology Northwestern University Chicago / Center for Health Sciences / University of California-Los Angeles / AMERICAN UROLOGICAL ASSOCIATION / Department of Urology / Medicare / /
Person
Mehran Movassaghi / Geoffrey Joyce / Christopher S. Saigal / Chris M. Gonzalez / Jennifer Pace / / /
Position
physician / /
Product
Medication After Procedure Procedure After Medication / finasteride / BPH Related Medication / tamsulosin / Hytrin / Initial medication / Age Group No. Pts Range Mean Median Entire cohort BPH medication / BPH medication / RL / Flomax / doxazosin mesylate / Cardura / Avodart / Proscar / /
ProvinceOrState
Illinois / California / /
RadioStation
Debruyne FM / /
Technology
laser / ultrasound / microwave / radio frequency / /
Economic Evaluation of Treatment Strategies for Benign Prostatic Hyperplasia—Is Medical Therapy More Costly in the Long Run? Christopher S. Saigal,* Mehran Movassaghi, Jennifer Pace, Geoffrey Joyce and the Urologic Dis